Cytlimic Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Out of Business

Cytlimic General Information

Description

Developer of cancer peptide vaccines intended to cure cancer. The company's products include innovative cancer peptide vaccines based on cancer immunology knowledge and technology, enabling patients to overcome cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3-4 oak Kanda Kajicho
  • 7F, Kanda Kajicho
  • Tokyo, Chiyoda-ku 101-0045
  • Japan
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 3-4 oak Kanda Kajicho
  • 7F, Kanda Kajicho
  • Tokyo, Chiyoda-ku 101-0045
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytlimic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Oct-2022 Completed Out of Business
2. Early Stage VC 09-Aug-2019 Completed Generating Revenue
1. Seed Round 19-Dec-2016 $8.75M $8.75M Completed Generating Revenue
To view Cytlimic’s complete valuation and funding history, request access »

Cytlimic Patents

Cytlimic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021106978-A1 Pharmaceutical composition Inactive 27-Nov-2019
CA-3039033-A1 Medicine Inactive 11-Oct-2016
JP-6998880-B2 Medicine Active 11-Oct-2016
JP-WO2018070069-A1 Medicine Active 11-Oct-2016
WO-2018070069-A1 Medicine Inactive 11-Oct-2016 A61K39/39
To view Cytlimic’s complete patent history, request access »

Cytlimic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytlimic FAQs

  • When was Cytlimic founded?

    Cytlimic was founded in 2016.

  • Where is Cytlimic headquartered?

    Cytlimic is headquartered in Tokyo, Japan.

  • What is the size of Cytlimic?

    Cytlimic has 1 total employees.

  • What industry is Cytlimic in?

    Cytlimic’s primary industry is Drug Discovery.

  • Is Cytlimic a private or public company?

    Cytlimic is a Private company.

  • What is Cytlimic’s current revenue?

    The current revenue for Cytlimic is .

  • How much funding has Cytlimic raised over time?

    Cytlimic has raised $20.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process